Clinical Trial Update: A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II trial evaluating the safety and efficacy of MPSK3169A in patients with coronary artery disease or at high ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• MPSK3169A

Snippet

Sponsor: Genentech, Inc. | Conditions: Coronary Heart Disease | Phase 2 | Status: COMPLETED